Cargando…

Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature

INTRODUCTION: Povidone iodine (PVP-I) 10% aqueous solution is a commonly utilized anti-septic employed for sterilization of the ocular surface prior to interventional procedures. Dimethylsulfoxide (DMSO) is a well-known skin penetration agent scarcely utilized in ophthalmic drug formulations. We des...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelletier, Jesse S., Stewart, Kevin P., Capriotti, Kara, Capriotti, Joseph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675729/
https://www.ncbi.nlm.nih.gov/pubmed/26525679
http://dx.doi.org/10.1007/s40123-015-0040-4
_version_ 1782405049842925568
author Pelletier, Jesse S.
Stewart, Kevin P.
Capriotti, Kara
Capriotti, Joseph A.
author_facet Pelletier, Jesse S.
Stewart, Kevin P.
Capriotti, Kara
Capriotti, Joseph A.
author_sort Pelletier, Jesse S.
collection PubMed
description INTRODUCTION: Povidone iodine (PVP-I) 10% aqueous solution is a commonly utilized anti-septic employed for sterilization of the ocular surface prior to interventional procedures. Dimethylsulfoxide (DMSO) is a well-known skin penetration agent scarcely utilized in ophthalmic drug formulations. We describe here a low-dose formulation of 1% PVP-I (w/w) in a gel containing DMSO for use in the setting of recalcitrant rosacea blepharoconjunctivitis. A review of the ocular uses of dimethylsulfoxide is also presented. CASE REPORT: A 78-year-old male presented with chronic, long-standing blepharitis involving both the anterior and posterior lid margins. Posterior lid and skin inflammatory changes were consistent with ocular rosacea. Previous oral and topical therapies had been largely ineffective at controlling his condition. CONCLUSION: The topical PVP-I/DMSO system was effective in abating the signs and symptoms of rosacea blepharoconjunctivitis. Further investigation of this novel agent is warranted. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40123-015-0040-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4675729
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-46757292015-12-18 Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature Pelletier, Jesse S. Stewart, Kevin P. Capriotti, Kara Capriotti, Joseph A. Ophthalmol Ther Case Report INTRODUCTION: Povidone iodine (PVP-I) 10% aqueous solution is a commonly utilized anti-septic employed for sterilization of the ocular surface prior to interventional procedures. Dimethylsulfoxide (DMSO) is a well-known skin penetration agent scarcely utilized in ophthalmic drug formulations. We describe here a low-dose formulation of 1% PVP-I (w/w) in a gel containing DMSO for use in the setting of recalcitrant rosacea blepharoconjunctivitis. A review of the ocular uses of dimethylsulfoxide is also presented. CASE REPORT: A 78-year-old male presented with chronic, long-standing blepharitis involving both the anterior and posterior lid margins. Posterior lid and skin inflammatory changes were consistent with ocular rosacea. Previous oral and topical therapies had been largely ineffective at controlling his condition. CONCLUSION: The topical PVP-I/DMSO system was effective in abating the signs and symptoms of rosacea blepharoconjunctivitis. Further investigation of this novel agent is warranted. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40123-015-0040-4) contains supplementary material, which is available to authorized users. Springer Healthcare 2015-11-02 2015-12 /pmc/articles/PMC4675729/ /pubmed/26525679 http://dx.doi.org/10.1007/s40123-015-0040-4 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
Pelletier, Jesse S.
Stewart, Kevin P.
Capriotti, Kara
Capriotti, Joseph A.
Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature
title Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature
title_full Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature
title_fullStr Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature
title_full_unstemmed Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature
title_short Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature
title_sort rosacea blepharoconjunctivitis treated with a novel preparation of dilute povidone iodine and dimethylsulfoxide: a case report and review of the literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675729/
https://www.ncbi.nlm.nih.gov/pubmed/26525679
http://dx.doi.org/10.1007/s40123-015-0040-4
work_keys_str_mv AT pelletierjesses rosaceablepharoconjunctivitistreatedwithanovelpreparationofdilutepovidoneiodineanddimethylsulfoxideacasereportandreviewoftheliterature
AT stewartkevinp rosaceablepharoconjunctivitistreatedwithanovelpreparationofdilutepovidoneiodineanddimethylsulfoxideacasereportandreviewoftheliterature
AT capriottikara rosaceablepharoconjunctivitistreatedwithanovelpreparationofdilutepovidoneiodineanddimethylsulfoxideacasereportandreviewoftheliterature
AT capriottijosepha rosaceablepharoconjunctivitistreatedwithanovelpreparationofdilutepovidoneiodineanddimethylsulfoxideacasereportandreviewoftheliterature